Sustaining Methadone Treatment During Lockdown
While the advent of the COVID-19 pandemic in early 2020 dominated the attention of global public health, the challenge of treating drug addiction and HIV – often co-occurring – was only complicated by fear of COVID-19 and the necessary restrictions imposed by governments to prevent transmission.
The Kyrgyz Republic is one of three countries in Central Asia, along with Kazakhstan and Tajikistan, where ICAP has been working since 2011, supporting HIV and tuberculosis services, particularly for people who inject drugs. In this context, ICAP’s focus shifted to ensuring that hard-won health gains to reach vulnerable populations in Kyrgyzstan would not be set back by the new pandemic.
In the context of the COVID-19 lockdown, the protocol in Kyrgyzstan for patients using medication-assisted therapy (MAT) to control their drug addiction needed to be rapidly transformed. The usual requirements involved the need for the clients to visit an MAT clinic every day for counseling and receive a limited supply of methadone. After six months, if the client met certain criteria, including negative urine tests and consistent medication usage, then the MAT site would issue an increased supply so clients could take the medication at home.
After the Kyrgyz government declared a state of emergency on March 22, 2020 in response to the worsening COVID-19 situation, ICAP collaborated with the Ministry of Health’s Republican Narcology Center (RNC) on plans to keep clients in MAT treatment, while minimizing the need for travel during the national quarantine and the risk of exposure to COVID-19. As part of these COVID-19 preventive measures, the RNC began to increase the number of MAT clients in Kyrgyzstan permitted to take home up to five daily doses of methadone supply.
“After almost nine months, we have seen great success with this new protocol and the proportion of clients on MAT who pick up methadone for 5-7 days increased from 36% to 97%.”
Ainagul Isakova,
ICAP program coordinator in Kyrgyzstan
Funding: The Global Fund to Fight AIDS, Tuberculosis, and Malaria and the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)
INVENTIVE
PREVENTIVE
SUSTAINABLE
Introducing and Scaling Up HIV Service Delivery Models
Against the backdrop of COVID-19, the 21 countries in the ICAP-supported Coverage, Quality and Impact Network (CQUIN) are collaborating to support resilient HIV prevention and treatment programs in the face of the pandemic. Launched in 2017 to support South-to-South learning and the scale-up of HIV differentiated service delivery (DSD), CQUIN pivoted in 2020 to a focus on maintaining HIV services in the midst of a global crisis.
Many countries built on their earlier experience with differentiated treatment models to ensure continuity of services during lockdowns. One example is multi-month antiretroviral therapy (ART) dispensing (MMD), in which receive three or six months of ART instead of a single month’s supply. In Ethiopia, ICAP has supported the Ethiopian Ministry of Health to scale up MMD since 2017. Currently, an estimated 170,000 clients at 1,051 health facilities across the country are enrolled in Ethiopia’s Appointment Spacing Model. Before MMD became the norm at Ethiopia’s Dessie Referral hospital, Aderaw Wegene, a construction worker, would spend time and money going back and forth between his jobs and the hospital to get his monthly ART refills. Now, after being enrolled in the new hospital program for 18 months, Wegene needs to go to the hospital only twice a year for ART. “It no longer affects my job and my life,” he said.
By mid-2020, multiple countries in the CQUIN network had expanded access to MMD in order to decrease the need for health facility visits during COVID-19. Ten countries expanded MMD eligibility, seven countries increased the amount of ART dispensed via MMD and nine enabled MMD of tuberculosis preventive treatment as well as ART. CQUIN supported cross-learning that helped to accelerate these nimble pandemic responses. For example, the ministries of health of Eswatini, Mozambique, Liberia, and Uganda leveraged lessons learned from Ethiopia to expand and scale up MMD. “This is just one example of how ICAP is leveraging the CQUIN project to foster real-time exchange of questions, resources, best practices and lessons learned,” said Miriam Rabkin, ICAP’s director of Health Systems Strategies and principal investigator of CQUIN. “Over the years, CQUIN has created a trusted and collegial network that facilitates this type of rapid and productive exchange.”
Funding: The Bill & Melinda Gates Foundation
More Impact Stories
Story One
Pivoting to Protect Vulnerable Populations
Story Two
Training Frontline Health Care Workers
As the COVID-19 pandemic arrived in Sierra Leone, ICAP's experience in health care worker training, mentoring and supportive supervision proved to be a critical asset.
Story Three
Researching Biomedical Responses to COVID-19
Recognizing the urgency of developing prevention and treatment responses to COVID-19.
Story Four
Saving Lives with Music
Story Five
Sustaining Methadone Treatment During Lockdown
Story Six
Harnessing Tech to Advance HIV Recency Testing
In the early days of the COVID pandemic, Zimbabwe had low infection rates, and people knew very little about the rapid global spread of the virus.
Story Seven
Surveying the HIV Epidemic Undaunted
Since 2014, the Population-based HIV Impact Assessment (PHIA) Project has been guiding the global HIV response by conducting national representative surveys that chart the state of the HIV epidemic across 15 countries.
Story Eight
Responding to Malaria in Remote Regions
For people who suffer from stigma and fear, including sex workers...
Story Nine
Confronting the Threat of Antimicrobial Resistance
While the rapid spread of COVID-19 continues to dominate headlines around the world, another health crisis looms large.
Story Ten
Connecting Key Populations to Care
For people who suffer from stigma and fear, including sex workers.